ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
PCOR
Procore Technologies, Inc.
PCOR has the edge over ASTS overall, supported by stronger fundamentals and lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PCOR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Weak |
PCOR's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is weak.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
PCOR PE Valuation
PCOR has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PCOR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for PCOR, with profitability improving. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
PCOR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.23 | — |
| Q3 2026 | -$0.23 | +$0.61 |
| Q2 2026 | -$0.26 | +$0.70 |
| Q1 2026 | -$0.51 | +$0.35 |
| Q4 2025 | -$0.67 | +$0.05 |
| Q3 2025 | -$0.84 | -$0.33 |
| Q2 2025 | -$0.96 | -$0.32 |
| Q1 2025 | -$0.86 | +$0.11 |
| Q4 2024 | -$0.72 | +$0.62 |
PCOR has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
PCOR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $402.3M | +19% |
| Q2 2026 | $375.2M | +16% |
| Q1 2026 | $359.3M | +16% |
| Q4 2025 | $349.1M | +16% |
| Q3 2025 | $338.9M | +15% |
| Q2 2025 | $323.9M | +14% |
| Q1 2025 | $310.6M | +15% |
| Q4 2024 | $302M | +16% |
PCOR's revenue has grown year over year every quarter since late 2020: $402M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.8% | +2.7 points |
| Q2 2026 | 1.1% | +11 points |
| Q1 2026 | -4.4% | +7.3 points |
| Q4 2025 | -12% | +9.7 points |
| Q3 2025 | -4.4% | +7.9 points |
| Q2 2025 | -9.3% | -4.1 points |
| Q1 2025 | -12% | -4.7 points |
| Q4 2024 | -22% | -7.6 points |
PCOR has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
PCOR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.5M | +10% |
| Q2 2026 | $80.9M | +190% |
| Q1 2026 | $73.8M | +19% |
| Q4 2025 | $109.2M | +527% |
| Q3 2025 | $83.1M | +133% |
| Q2 2025 | $27.9M | -51% |
| Q1 2025 | $62M | -7.5% |
| Q4 2024 | $17.4M | -55% |
PCOR has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PCOR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.5x | High |
| Q2 2026 | -10.5x | Net Cash |
| Q1 2026 | -42.3x | Net Cash |
PCOR's net debt is about 6.5 years of its operating earnings (EBITDA).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
PCOR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.9 | Neutral |
| Stochastic | 87.5 | Overbought |
PCOR's weekly RSI is 69 (neutral) and its Stochastic is 87 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
PCOR PE vs Technology Sector
PCOR has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
PCOR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.3 | 26% above |
| 20 week MA | $56.4 | 37% above |
| 50 week MA | $56.9 | 36% above |
| 100 week MA | $64.0 | 21% above |
| 200 week MA | $64.7 | 19% above |
PCOR has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
PCOR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $88.6 | $81.7 | -7.8% |
| 2022 | $81.7 | $47.9 | -41% |
| 2023 | $47.9 | $69.2 | +44% |
| 2024 | $69.2 | $76.4 | +10% |
| 2025 | $76.4 | $74.5 | -2.4% |
| 2026 YTD | $74.5 | $77.2 | +3.6% |
PCOR has the edge over ASTS on returns for 2026, with the stronger performance.